| Financial Year |
March 31 2023 |
| Monetary Funds |
1,200,215,141.52 |
| Held-for-trading Financial Assets |
44,983,019.43 |
| Notes Receivable |
74,364,300.79 |
| Accounts Receivable |
1,284,117,690.53 |
| Advances to Suppliers |
116,196,438.32 |
| Other Receivables |
15,997,025.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,571,474,616.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
36,367,496.84 |
| Total Current Assets |
4,715,448,801.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,983,595.02 |
| Investment Properties |
38,870,497.14 |
| Fixed Assetes |
465,893,170.05 |
| Under-construction Projects |
418,762,125.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
79,893,421.90 |
| R&D expenses |
-- |
| Goodwill |
208,780,772.08 |
| Long-Term Deferred and Prepaid Expenses |
27,079,374.72 |
| Deferred Income Tax Assets |
65,439,658.15 |
| Other Non-Current Assets |
20,581,852.47 |
| Sub-Total of Non-Current Assets |
1,651,360,276.71 |
| Total Assets |
6,366,809,078.23 |
| Short-Term Loans |
499,020,789.19 |
| Trading Financial liabilities |
-- |
| Notes Payable |
395,506,587.77 |
| Accounts Payable |
916,427,453.43 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
106,245,898.44 |
| Taxes Payable |
20,334,116.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
128,470,376.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,941,325.31 |
| Other Current Liabilities |
93,839,981.53 |
| Sub-Total of Current Liabilities |
3,145,670,172.20 |
| Long-term Loans |
41,810,553.36 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
15,169,888.54 |
| Deferred Income Tax Liabilities |
11,117,985.73 |
| Other Non-Current Liabilities |
10,100.00 |
| Sub-Total of Non-Current Liabilities |
116,624,996.03 |
| Total Liabilities |
3,262,295,168.23 |
| Paid-In Capital(Or Share Stock) |
410,762,170.00 |
| Capital Surplus |
777,931,227.36 |
| Surplus Reserve |
161,426,545.34 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,475,172,635.05 |
| Minority Stockholder's Interest |
295,421,705.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,809,092,204.93 |
| Owner's Equity（Stockholder's Equity） |
3,104,513,910.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,366,809,078.23 |
